On the public citation graph

A thermostable messenger RNA based vaccine against rabies

https://doi.org/10.1371/journal.pntd.0006108
0 signed · 135 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1521-4141(200001)30:1<1::aid-immu1>3.0.co;2-#openalex-snapshot
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
inferredcites →https://doi.org/10.1007/978-3-540-72167-3_11openalex-snapshot
Vaccination with Messenger RNA (mRNA)
inferredcites →https://doi.org/10.1016/j.vaccine.2006.08.028openalex-snapshot
A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries
inferredcites →https://doi.org/10.1016/j.vaccine.2007.02.052openalex-snapshot
Freezing temperatures in the vaccine cold chain: A systematic literature review
inferredcites →https://doi.org/10.1016/j.vaccine.2011.05.070openalex-snapshot
Vaccine stabilization: Research, commercialization, and potential impact
inferredcites →https://doi.org/10.1016/j.vaccine.2015.03.025openalex-snapshot
Rabies vaccine preserved by vaporization is thermostable and immunogenic
inferredcites →https://doi.org/10.1016/j.vaccine.2016.10.015openalex-snapshot
Thermotolerance of an inactivated rabies vaccine for dogs
inferredcites →https://doi.org/10.1016/j.vetmic.2008.10.030openalex-snapshot
Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein
inferredcites →https://doi.org/10.1016/s0022-1759(97)00212-3openalex-snapshot
Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody
inferredcites →https://doi.org/10.1016/s0140-6736(17)31665-3openalex-snapshot
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
inferredcites →https://doi.org/10.1038/nbt.2436openalex-snapshot
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
inferredcites →https://doi.org/10.1097/cji.0b013e3181f7dbe8openalex-snapshot
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
inferredcites →https://doi.org/10.1371/journal.pntd.0004746openalex-snapshot
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
inferredcites →https://doi.org/10.1517/17425247.2014.901308openalex-snapshot
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
inferredcites →https://doi.org/10.1586/erv.09.20openalex-snapshot
Opportunities and challenges of developing thermostable vaccines
inferredcites →https://doi.org/10.2144/000112593openalex-snapshot
Long-Term Storage of DNA-Free RNA for use in Vaccine Studies
inferredcites →https://doi.org/10.4161/hv.1.5.2110openalex-snapshot
Assessing the Relationship between Antigenecity and Immunogenecity of Human Rabies Vaccines: Results of a Meta-Analysis
inferredcites →https://doi.org/10.4161/hv.5.1.6494openalex-snapshot
Characterization of the freeze sensitivity of a hepatitis B vaccine

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3178506openalex-extracted
Eradication of Rabies with Mass Parental Vaccination, Human Post-Exposure Prophylaxis, and Gene Therapy: A Systematic Review
inferred← citeshttps://doi.org/10.1002/adma.202308029openalex-snapshot
Engineered mRNA Delivery Systems for Biomedical Applications
inferred← citeshttps://doi.org/10.1002/adtp.201800065openalex-snapshot
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
inferred← citeshttps://doi.org/10.1002/adtp.202300255openalex-snapshot
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
inferred← citeshttps://doi.org/10.1002/jmv.28572openalex-snapshot
mRNA vaccines: The future of prevention of viral infections?
inferred← citeshttps://doi.org/10.1002/jmv.28924openalex-snapshot
Advances in mRNA vaccines for viral diseases
inferred← citeshttps://doi.org/10.1007/82_2020_202openalex-snapshot
Messenger RNA-Based Vaccines Against Infectious Diseases
inferred← citeshttps://doi.org/10.1007/82_2020_217openalex-snapshot
Formulation and Delivery Technologies for mRNA Vaccines
inferred← citeshttps://doi.org/10.1007/82_2020_230openalex-snapshot
mRNA-Based Vaccines and Mode of Action
inferred← citeshttps://doi.org/10.1007/978-1-0716-3770-8_1openalex-snapshot
Introduction to RNA Vaccines Post COVID-19
inferred← citeshttps://doi.org/10.1007/978-3-031-24323-3_6openalex-snapshot
Applications of Spray-Dried Vaccines
inferred← citeshttps://doi.org/10.1007/s10557-022-07391-3openalex-snapshot
RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease
inferred← citeshttps://doi.org/10.1007/s11095-026-04132-1openalex-snapshot
Osmolyte-Based Formulations for Enhanced Thermal Stability of mRNA Drug Substance: A Systematic Screening and Optimization Study
inferred← citeshttps://doi.org/10.1007/s12033-023-00759-2openalex-snapshot
Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems
inferred← citeshttps://doi.org/10.1007/s40290-021-00417-5openalex-snapshot
Delivery Strategies for mRNA Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-12-814357-5.00002-7openalex-snapshot
Lyophilized vaccine development
inferred← citeshttps://doi.org/10.1016/b978-0-12-814357-5.00007-6openalex-snapshot
pDNA and mRNA vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-443-15378-5.00015-2openalex-snapshot
Production of rabies vaccine in the large-scale bioreactor
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.01.002openalex-snapshot
RNA therapeutics for infectious diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2020.12.006openalex-snapshot
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.016openalex-snapshot
Stability of lyophilized and spray dried vaccine formulations
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113834openalex-snapshot
Nucleic acid delivery for therapeutic applications
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114313openalex-snapshot
Stabilizing vaccines via drying: Quality by design considerations
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114972openalex-snapshot
Polyplex designs for improving the stability and safety of RNA therapeutics
inferred← citeshttps://doi.org/10.1016/j.ajps.2020.08.001openalex-snapshot
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
inferred← citeshttps://doi.org/10.1016/j.ajps.2022.05.003openalex-snapshot
mRNA vaccines: Past, present, future
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.09.009openalex-snapshot
Advances and prospects of RNA delivery nanoplatforms for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111953openalex-snapshot
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.bpj.2024.04.010openalex-snapshot
Map conformational landscapes of intrinsically disordered proteins with polymer physics quantities
inferred← citeshttps://doi.org/10.1016/j.cell.2020.07.024openalex-snapshot
A Thermostable mRNA Vaccine against COVID-19
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103458openalex-snapshot
Current state of, prospects for, and obstacles to mRNA vaccine development
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e26971openalex-snapshot
The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143134openalex-snapshot
mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.120586openalex-snapshot
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124344openalex-snapshot
Design of novel chiral self-assembling peptides to explore the efficiency and mechanism of mRNA-FIPV vaccine delivery vehicles
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112320openalex-snapshot
mRNA vaccines against infectious diseases and future direction
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.11.009openalex-snapshot
Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.03.032openalex-snapshot
mRNA vaccines for COVID-19 and diverse diseases
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.03.033openalex-snapshot
Delivery of mRNA for regulating functions of immune cells
inferred← citeshttps://doi.org/10.1016/j.nantod.2023.102038openalex-snapshot
A rabies mRNA vaccine provides a rapid and long-term immune response in mice
inferred← citeshttps://doi.org/10.1016/j.omtm.2022.03.009openalex-snapshot
A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery
inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102721openalex-snapshot
mRNA therapeutics: Transforming medicine through innovation in design, delivery, and disease treatment
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106699openalex-snapshot
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
inferred← citeshttps://doi.org/10.1016/j.procbio.2022.11.011openalex-snapshot
Rabies vaccine: Recent update and comprehensive review of in vitro and in vivo studies
inferred← citeshttps://doi.org/10.1016/j.trac.2026.119179openalex-snapshot
Analytical and functional characterization of next-generation therapeutics: ADCs, CAR-T cells, rAAVs, mRNA and VLPs
inferred← citeshttps://doi.org/10.1016/j.vaccine.2021.02.023openalex-snapshot
Biosecurity risks associated with vaccine platform technologies
inferred← citeshttps://doi.org/10.1016/j.xphs.2020.12.006openalex-snapshot
Addressing the Cold Reality of mRNA Vaccine Stability
inferred← citeshttps://doi.org/10.1016/j.xphs.2022.11.001openalex-snapshot
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
inferred← citeshttps://doi.org/10.1016/j.ymthe.2019.01.020openalex-snapshot
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.8b00207openalex-snapshot
Stabilization of RNA Encapsulated in Silk
inferred← citeshttps://doi.org/10.1021/jacs.1c08484openalex-snapshot
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics
inferred← citeshttps://doi.org/10.1038/s41392-022-00950-yopenalex-snapshot
Advances in COVID-19 mRNA vaccine development
inferred← citeshttps://doi.org/10.1038/s41541-021-00311-wopenalex-snapshot
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
inferred← citeshttps://doi.org/10.1038/s41541-021-00317-4openalex-snapshot
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
inferred← citeshttps://doi.org/10.1038/s41541-022-00549-yopenalex-snapshot
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
inferred← citeshttps://doi.org/10.1038/s41541-024-00925-wopenalex-snapshot
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques
inferred← citeshttps://doi.org/10.1038/s41573-021-00283-5openalex-snapshot
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
inferred← citeshttps://doi.org/10.1038/s41586-021-04231-6openalex-snapshot
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
inferred← citeshttps://doi.org/10.1038/s41598-020-78009-7openalex-snapshot
Infectious RNA vaccine protects mice against chikungunya virus infection
inferred← citeshttps://doi.org/10.1038/s41598-025-16143-wopenalex-snapshot
A novel mRNA-based multi-epitope vaccine for rabies virus computationally designed via reverse vaccinology and immunoinformatics
inferred← citeshttps://doi.org/10.1039/d3tb00308fopenalex-snapshot
Next-generation materials for RNA–lipid nanoparticles: lyophilization and targeted transfection
inferred← citeshttps://doi.org/10.1080/14760584.2019.1627205openalex-snapshot
Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination
inferred← citeshttps://doi.org/10.1080/14760584.2022.2053678openalex-snapshot
Thermostable vaccines: an innovative concept in vaccine development
inferred← citeshttps://doi.org/10.1080/17425247.2022.2135502openalex-snapshot
Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications
inferred← citeshttps://doi.org/10.1080/17460794.2026.2667092openalex-snapshot
Working toward a single-dose vaccine for rabies post-exposure prophylaxis
inferred← citeshttps://doi.org/10.1080/21645515.2022.2040330openalex-snapshot
mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
inferred← citeshttps://doi.org/10.1080/22221751.2023.2270081openalex-snapshot
A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs
inferred← citeshttps://doi.org/10.1088/1748-605x/acecebopenalex-snapshot
Future prospects in mRNA vaccine development
inferred← citeshttps://doi.org/10.1101/2020.12.23.424138openalex-snapshot
mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
inferred← citeshttps://doi.org/10.1101/2021.05.13.443734openalex-snapshot
Optimised non-coding regions of mRNA SARS-CoV-2 vaccine CV2CoV improves homogeneous and heterogenous neutralising antibody responses
inferred← citeshttps://doi.org/10.1101/2021.08.13.456316openalex-snapshot
Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
inferred← citeshttps://doi.org/10.1111/cas.14784openalex-snapshot
Personalized cancer vaccination in head and neck cancer
inferred← citeshttps://doi.org/10.1128/spectrum.04240-22openalex-snapshot
mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
inferred← citeshttps://doi.org/10.1146/annurev-bioeng-110220-031722openalex-snapshot
Current Developments and Challenges of mRNA Vaccines
inferred← citeshttps://doi.org/10.1186/s12943-021-01311-zopenalex-snapshot
mRNA vaccine: a potential therapeutic strategy
inferred← citeshttps://doi.org/10.1186/s12985-023-02023-0openalex-snapshot
Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
inferred← citeshttps://doi.org/10.1208/s12248-021-00676-9openalex-snapshot
Nano/microparticle Formulations for Universal Influenza Vaccines
inferred← citeshttps://doi.org/10.12688/gatesopenres.16382.1openalex-snapshot
Qualification of a quantitative stability indicating potency assay for mRNA-LNP vaccine candidates
inferred← citeshttps://doi.org/10.1360/ssv-2021-0376openalex-snapshot
mRNA疗法的研究进展与挑战
inferred← citeshttps://doi.org/10.1371/journal.pntd.0004746openalex-snapshot
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
inferred← citeshttps://doi.org/10.2147/cpaa.s418314openalex-snapshot
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
inferred← citeshttps://doi.org/10.2174/0115672018320938241121075859openalex-snapshot
mRNA Vaccines: Unlocking Potential, Exploring Applications, and Envisioning Future Horizons
inferred← citeshttps://doi.org/10.2174/0124681873339647250214070805openalex-snapshot
Revolutionizing Disease Prevention: The Rise of mRNA Vaccines and Nanotechnology for the Treatment of Cancer and Infectious Diseases
inferred← citeshttps://doi.org/10.22088/ijmcm.bums.11.3.260openalex-snapshot
Current Perspectives and Future Prospects of mRNA Vaccines against Viral Diseases: A Brief Review.
inferred← citeshttps://doi.org/10.25026/jsk.v3i6.444openalex-snapshot
Covid-19 and Its Vaccine Development: A Narrative Review
inferred← citeshttps://doi.org/10.31926/jmb.2021.1.6openalex-snapshot
Vaccinuri ARNM: istoric, necesități, domenii de utilizare | [MRNA vaccines: history, needs, areas of use]
inferred← citeshttps://doi.org/10.3389/fcell.2023.1198848openalex-snapshot
Applications of advances in mRNA-based platforms as therapeutics and diagnostics in reproductive technologies
inferred← citeshttps://doi.org/10.3389/fimmu.2019.00594openalex-snapshot
Advances in mRNA Vaccines for Infectious Diseases
inferred← citeshttps://doi.org/10.3389/fimmu.2020.608460openalex-snapshot
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1288879openalex-snapshot
An mRNA vaccine against rabies provides strong and durable protection in mice
inferred← citeshttps://doi.org/10.3390/biologics1030020openalex-snapshot
Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
inferred← citeshttps://doi.org/10.3390/biologics3040020openalex-snapshot
mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
inferred← citeshttps://doi.org/10.3390/cells15181673openalex-snapshot
mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers
inferred← citeshttps://doi.org/10.3390/genes13122287openalex-snapshot
Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency
inferred← citeshttps://doi.org/10.3390/life12081254openalex-snapshot
The Delivery of mRNA Vaccines for Therapeutics
inferred← citeshttps://doi.org/10.3390/microorganisms13020380openalex-snapshot
Infection and Prevention of Rabies Viruses
inferred← citeshttps://doi.org/10.3390/molecules27144457openalex-snapshot
Medicinal Fungi with Antiviral Effect
inferred← citeshttps://doi.org/10.3390/pathogens11010069openalex-snapshot
Rabies Vaccination in Dogs in Laos: Owner Knowledge and Serological Status of Dogs
inferred← citeshttps://doi.org/10.3390/pharmaceutics13010045openalex-snapshot
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
inferred← citeshttps://doi.org/10.3390/v13020258openalex-snapshot
The Key Role of Nucleic Acid Vaccines for One Health
inferred← citeshttps://doi.org/10.3390/v14020401openalex-snapshot
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
inferred← citeshttps://doi.org/10.3390/vaccines10081251openalex-snapshot
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
inferred← citeshttps://doi.org/10.3390/vaccines10111794openalex-snapshot
An Overview of Rift Valley Fever Vaccine Development Strategies
inferred← citeshttps://doi.org/10.3390/vaccines13010030openalex-snapshot
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
inferred← citeshttps://doi.org/10.3390/vaccines13080853openalex-snapshot
Freeze-Drying of mRNA-LNPs Vaccines: A Review
inferred← citeshttps://doi.org/10.3390/vaccines7020037openalex-snapshot
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
inferred← citeshttps://doi.org/10.3390/vaccines7040122openalex-snapshot
Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
inferred← citeshttps://doi.org/10.3390/vaccines9010061openalex-snapshot
Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
inferred← citeshttps://doi.org/10.3390/vaccines9090965openalex-snapshot
An Update on mRNA-Based Viral Vaccines
inferred← citeshttps://doi.org/10.3390/vaccines9091033openalex-snapshot
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
inferred← citeshttps://doi.org/10.3390/zoonoticdis4040021openalex-snapshot
The Value of a Comparative Approach with Equine Vaccine Development for the Development of Human Influenza DNA Vaccines
inferred← citeshttps://doi.org/10.36877/pmmb.a0000100openalex-snapshot
Updates on the development of vaccines and therapeutic options against rabies
inferred← citeshttps://doi.org/10.3892/ijo.2024.5669openalex-snapshot
mRNA vaccine development and applications: A special focus on tumors (Review)
inferred← citeshttps://doi.org/10.3892/wasj.2025.378openalex-snapshot
Advances in in silico drug discovery for rabies virus: Innovations in ligand identification and therapeutic mechanisms (Review)
inferred← citeshttps://doi.org/10.53964/cme.2025001openalex-snapshot
mRNA Technology in Modern Medicine: Review and Future Prospects
inferred← citeshttps://doi.org/10.54097/6apbkw71openalex-snapshot
Mechanism, applications and of mRNA vaccines
inferred← citeshttps://doi.org/10.9734/ajrimps/2018/43202openalex-snapshot
Eradication of Rabies with Mass Parental Vaccination, Post-exposure Prophylaxis and Gene Therapy: A Systematic Review
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.